Federal Register / Vol. 53, No. 122 / Friday. June 24, 
The Assessment Process 
The assessment is conducted by a 
four member Local Assessment Team, or 
LAT. Each member has an important 
role. 
1. The Candidate. A full member of 
the LAT, the Candidate has an equal 
voice in assessing her/his own 
competence. The Candidate compiles 
evidence to demonstrate competence in 
the 13 Functional Areas. This compiled 
material is in the form of a Portfolio. 
{Information on putting together the 
Portfolio will be supplied by the CDA 
National Credentialing Program after 
one applies.) 
2. The Ach/fsor. This member of the 
LAT is selected by the Candidate. The 
Advisor is an early childhood 
professional who may be a college 
professor, a CDA trainer, a CDA. a 
center director, or someone else. The 
Advisor establishes a professional 
relationship with the Candidate over 
time, observes the Candidate’s 
performance, provides assistance and 
feedback, and helps the Candidate 
decide when to be assessed. 
3. The Porentf Community 
Representative f P/C Rep). Also selected 
by the Candidate, the P/C Rep must be 
or have been a parent or guardian of a 
child five years old or younger. The P/C 
Rep must have been recently involved 
with the Candidate’s program as a 
parent or volunteer, but must not be a 
current employee. Furthermore, the P/C 
Rep must not have a child currently in 
the Candidate's care. The P/C Rep 
servds as the spokesperson on the LAT 
for the parents and the community. To 
do this, the P/C Rep gets questionnaires 
filled out by the parents of children in 
the Candidate's care and observes the 
Candidate working with the children 
and their families. 
4. The CDA Representative (CDA 
Rep). Assigned by the CDA National 
Credentialing Program, the CDA Rep is 
a professional in early childhood 
education who has worked with young 
children in a child development setting. 
The CDA Rep has been trained to 
observe, interview, make fair judgments, 
and verify that procedures are followed. 
The CDA Rep observes the Candidate, 
interviews the Candidate, and 
participates in the LAT meetings at 
which the Candidate’s competence is 
assessed. 
The Local Assessment Team (LAT) 
Meeting 
Each of the four team members 
collects information about the 
Candidate's skills in working with young 
children. After the information is 
gathered, the team members attend the 
LAT meeting. The LAT reviews the 
materials that have been compiled, 
examines the Candidate’s performance 
in each of the 13 Functional Areas, and 
decides if the Candidate has met the 
CDA Competency Standards. For 
bilingual assessments, the LAT also 
looks for demonstrated skill in the use of 
both languages. Each team member has 
equal importance in judging the 
Candidate's competence. This means 
that the Candidate participates fully in 
the process. At the completion of the 
meeting, the LAT votes on the 
Candidate's overall competence. The 
LAT may recommend that the 
Candidate be awarded the CDA 
Credential or it may decide that the 
Candidate needs more training. In order 
to recommend that the Candidate 
receive the CDA Credential, however, 
all team members must agree that the 
Candidate is competent. 
. The CDA Representative sends all the 
meeting materials to the CDA National 
Credentialing Program for review and 
verification. Depending on how the LAT 
voted, the Candidate rs then either 
awarded the CDA Credential or advised 
to seek more training. 
How Long It Takes 
The assessment system is designed 
for Candidates to progress at their own 
pace. Some take longer than others. 
Much depends on how fast the 
Candidates, and those with whom they 
work, can collect the information 
needed for assessment. The important 
thing is that assessments should not 
take place until Candidates feel they are 
ready. 
/ 
Cost to the Candidate 
The total cost for a CDA assessment 
and Credential is $325. Two separate 
fees are paid, as follows: 
525.00 registration fee; 
5300.00 assessment and credentialing 
fee. 
For CDAs who wish a second 
credential in an additional program 
setting, a Dual Credential pilot project 
has begun, costing S225. For example, an 
individual with a CDA in Center-based 
programs may wish to earn an 
additional credential as a home visitor. 
1988 / Notices 238Q5 
These fees are in effect through 
August. 1S38. For further information on 
current CDA Candidate fees, please 
contact the CDA National Credentialing 
Program (800) 424-4310 or (202) 265- 
9090. 
[FR Doc. 08-14311 Filed 6-23-88: 8:45 amj 
BILLING CODE 4130-01 -M 
National Institutes of Health 
Recombinant DNA Advisory 
Committee, Human Gene Therapy 
Subcommittee; Meeting 
Pursuant to Pub. L. 92—463, notice is 
hereby given of a meeting of the 
Recombinant DNA Advisory Committee 
Human Gene Therapy Subcommittee at 
the National Institutes of Health. 
Building 31C, Conference Room 9, 9COO 
Rockville Pike, Bethesda, Maryland 
20392, on July 29, 1983, from 
approximately 9:00 a.m. to adjournment 
at approximately 5:00 p.m. to review a 
human gene transfer protocol submitted 
by Drs. Steven A. Ro3enbeTg, R. Michael 
Blaese. and W. French Amderson. This 
meeting will be open to the public; 
Attendance by the public will be limited 
to space available. 
Further information maybe obtained 
from Dr. William. J. Gartland, Executive 
Secretary, Recombinant DNA Advisory 
Committee Human Gene Therapy 
Subcommittee, Office of Recombinant 
DNA Activities. 12441 Parklawn Drive, 
Suite 33. Rockville, Maryland 20552. 
telephone {301) 770-0131. 
OMB's “Mandatory Information 
Requirements for Federal Assistance Program 
Announcements" (45 FR 39592) requires a 
statement concerning the official government 
programs contained in the Catalog of Federal 
Domestic Assistance. Normally NIH lists in 
its announcements the number and title of 
affected individual programs for the guidance 
of the public. Because the guidance in this 
notice covers not only virtually every NTH 
program but also essentially every Federal 
research program in which DNA recombinant 
molecule techniques could be used, it has 
been determined to be not cost effective or ht 
the public interest to attempt to list these 
programs. Such a list would likely require 
several additional pages. In addition, NIH 
could not be certain that every Federal 
program would be included as many Federal 
agencies, as well as private organizations, 
both national and international, have elected 
to follow the NIH Guidelines. In lieu of the 
individual program listing. NIH invites 
[176] 
Recombinant DNA Research, Volume 13 
